PHARMAIDS PHARMACEUTICALS LTD. (PHARMAID) reported revenue of ₹4.12 Cr and net profit of ₹1.87 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from PHARMAIDS PHARMACEUTICALS LTD.’s filed results, 11 filed quarters and 5 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 12, 2026
| ₹ Cr | Jun2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | — | 5.81 | 4.67 | 5.24 | 4.71 | 4.77 | 6.66 | 8.61 | 5.43 | 7.18 | 4.12 | -38.2% |
| 1.61 | 11.4 | 8.08 | 7.65 | 7.60 | 8.68 | 12.1 | 13.9 | 7.93 | 7.52 | 4.87 | -59.7% | |
| Operating profit | — | -5.58 | -3.40 | -2.41 | -2.89 | -3.91 | -5.41 | -5.32 | -2.50 | -0.34 | -0.74 | n/m |
| OPM % | — | -96.1% | -72.8% | -46.0% | -61.4% | -82.0% | -81.2% | -61.9% | -46.1% | -4.7% | -18.1% | +63.1 pp |
| Other income | 0.37 | 0.12 | 0.01 | 0.08 | 0.00 | 0.07 | 0.04 | 0.22 | 0.08 | 0.10 | 0.05 | +20.4% |
| Interest | 0.00 | 0.77 | 0.26 | 0.33 | 0.48 | 1.01 | 1.20 | 1.08 | 0.72 | 0.65 | 0.60 | -49.5% |
| Depreciation | 0.01 | 0.63 | 0.57 | 0.61 | 0.64 | 0.62 | 0.61 | 0.47 | 0.48 | 0.48 | 0.49 | -19.9% |
| Profit before tax | -1.21 | — | -4.30 | -3.27 | -4.01 | -5.40 | -7.17 | -3.66 | -4.02 | -1.46 | 2.41 | n/m |
| Tax % | n/a (loss) | — | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | 22.5% | — |
| Net profit | -1.30 | -6.33 | -3.12 | -2.27 | -3.01 | -4.80 | -5.32 | -2.53 | -2.65 | -1.09 | 1.87 | n/m |
| EPS (₹) | — | — | — | -0.55 | -0.55 | -1.11 | -1.41 | -0.70 | -0.70 | -0.51 | 0.63 | n/m |
